Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diabetes

  Free Subscription


24.04.2017

1 Am J Cardiol
2 Ann Intern Med
2 Circ Cardiovasc Qual Outcomes
1 Circulation
4 Diabet Med
5 Diabetes
14 Diabetes Care
3 Diabetes Educ
4 Diabetes Obes Metab
1 Eur J Endocrinol
1 Invest Ophthalmol Vis Sci
7 J Diabetes Complications
1 J Nutr
1 Metabolism
2 N Engl J Med
3 Pediatr Diabetes
7 PLoS One
2 Retina


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Cardiol

  1. ERTELT K, Brener SJ, Mehran R, Ben-Yehuda O, et al
    Comparison of Outcomes and Prognosis of Patients With Versus Without Newly Diagnosed Diabetes Mellitus After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (the HORIZONS-AMI Study).
    Am J Cardiol. 2017 Mar 29. pii: S0002-9149(17)30339.
    PubMed     Text format     Abstract available


    Ann Intern Med

  2. JASIM S, Smith SA
    Review: Metformin is linked to reduced mortality in type 2 diabetes with comorbid CKD and CHF.
    Ann Intern Med. 2017;166:JC46.
    PubMed     Text format    

  3. RODRIGUEZ-GUTIERREZ R, Montori VM
    Guideline: In type 2 diabetes, ACP recommends metformin monotherapy if drugs are needed for glycemic control.
    Ann Intern Med. 2017;166:JC39.
    PubMed     Text format    


    Circ Cardiovasc Qual Outcomes

  4. RAGHAVAN S, Matlock D
    Diabetes Mellitus Treatment Deintensification: When Well-Controlled Diabetes Mellitus Becomes Overcontrolled.
    Circ Cardiovasc Qual Outcomes. 2017;10.
    PubMed     Text format    

  5. MCALISTER FA, Youngson E, Eurich DT
    Treatment Deintensification Is Uncommon in Adults With Type 2 Diabetes Mellitus: A Retrospective Cohort Study.
    Circ Cardiovasc Qual Outcomes. 2017;10.
    PubMed     Text format     Abstract available


    Circulation

  6. RAWSHANI A, Rawshani A, Franzen S, Eliasson B, et al
    Range of Risk Factor Levels: Control, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes Mellitus.
    Circulation. 2017;135:1522-1531.
    PubMed     Text format     Abstract available


    Diabet Med

  7. HOLT RIG
    Diabetes technology.
    Diabet Med. 2017;34:603.
    PubMed     Text format    

  8. SULTAN A, Perriard F, Macioce V, Mariano-Goulart D, et al
    Evolution of silent myocardial ischaemia prevalence and cardiovascular disease risk factor management in Type 2 diabetes over a 10-year period: an observational study.
    Diabet Med. 2017 Apr 18. doi: 10.1111/dme.13364.
    PubMed     Text format     Abstract available

  9. MORGAN NG
    Bringing the human pancreas into focus: new paradigms for the understanding of Type 1 diabetes.
    Diabet Med. 2017 Apr 20. doi: 10.1111/dme.13365.
    PubMed     Text format     Abstract available

  10. COATES VE, Horigan G, Davies M, Davies MT, et al
    Exploring why young people with Type 1 diabetes decline structured education with a view to overcoming barriers.
    Diabet Med. 2017 Apr 21. doi: 10.1111/dme.13368.
    PubMed     Text format     Abstract available


    Diabetes

  11. EMDIN CA, Klarin D, Natarajan P, Florez JC, et al
    Genetic Variation at the Sulfonylurea Receptor, Type 2 Diabetes, and Coronary Heart Disease.
    Diabetes. 2017 Apr 14. pii: db170149. doi: 10.2337/db17-0149.
    PubMed     Text format     Abstract available

  12. ROOIJACKERS HM, Wiegers EC, van der Graaf M, Thijssen DH, et al
    A Single Bout of High-Intensity Interval Training Reduces Awareness of Subsequent Hypoglycemia in Patients with Type 1 Diabetes.
    Diabetes. 2017 Apr 18. pii: db161535. doi: 10.2337/db16-1535.
    PubMed     Text format     Abstract available

  13. LO CS, Shi Y, Chenier I, Ghosh A, et al
    Heterogeneous Nuclear Ribonucleoprotein F Stimulates Sirtuin-1 Gene Expression and Attenuates Nephropathy Progression in Diabetic Mice.
    Diabetes. 2017 Apr 19. pii: db161588. doi: 10.2337/db16-1588.
    PubMed     Text format     Abstract available

  14. XU H, Ryan KA, Jaworek TJ, Southam L, et al
    Familial Hypercholesterolemia and Type 2 Diabetes in the Old Order Amish.
    Diabetes. 2017 Apr 20. pii: db170173. doi: 10.2337/db17-0173.
    PubMed     Text format     Abstract available

  15. AL-JOBORI H, Daniele G, Cersosimo E, Triplitt C, et al
    Empagliflozin and Kinetics of Renal Glucose Transport in Healthy and Type 2 Diabetic Individuals.
    Diabetes. 2017 Apr 20. pii: db170100. doi: 10.2337/db17-0100.
    PubMed     Text format     Abstract available


    Diabetes Care

  16. RAJASEKERAN H, Kim SJ, Cardella CJ, Schiff J, et al
    Use of Canagliflozin in Kidney Transplant Recipients for the Treatment of Type 2 Diabetes: A Case Series.
    Diabetes Care. 2017 Apr 17. pii: dc170237. doi: 10.2337/dc17-0237.
    PubMed     Text format    

  17. ROSENSTOCK J, Aronson R, Grunberger G, Hanefeld M, et al
    Erratum. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial
    Diabetes Care. 2017 Apr 18. pii: dc17er06c. doi: 10.2337.
    PubMed     Text format    

  18. MITA T, Katakami N, Shiraiwa T, Yoshii H, et al
    Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes
    Diabetes Care. 2017 Apr 18. pii: dc17er06a. doi: 10.2337.
    PubMed     Text format    

  19. KAZDA CM, Ding Y, Kelly RP, Garhyan P, et al
    Erratum. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249.
    Diabetes Care. 2017 Apr 18. pii: dc17er06. doi: 10.2337.
    PubMed     Text format    

  20. MITA T, Katakami N, Yoshii H, Onuma T, et al
    Erratum. Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A). Diabetes Care 2016;39:1
    Diabetes Care. 2017 Apr 18. pii: dc17er06b. doi: 10.2337.
    PubMed     Text format    

  21. DUBOIS-LAFORGUE D, Cornu E, Saint-Martin C, Coste J, et al
    Diabetes, Associated Clinical Spectrum, Long-term Prognosis and Genotype/Phenotype Correlations in 201 Adult Patients With Hepatocyte Nuclear Factor 1 B (HNF1B) Molecular Defects.
    Diabetes Care. 2017 Apr 18. pii: dc162462. doi: 10.2337/dc16-2462.
    PubMed     Text format     Abstract available


  22. In This Issue of Diabetes Care.
    Diabetes Care. 2017;40:627-628.
    PubMed     Text format    

  23. PICKUP JC, Reznik Y, Sutton AJ
    Glycemic Control During Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Insulin Injections in Type 2 Diabetes: Individual Patient Data Meta-analysis and Meta-regression of Randomized Controlled Trials.
    Diabetes Care. 2017;40:715-722.
    PubMed     Text format     Abstract available

  24. JACKSON J, Posgai A, Campbell-Thompson M, Kusmartseva I, et al
    Insulitis in Autoantibody-Positive Pancreatic Donor With History of Gestational Diabetes Mellitus.
    Diabetes Care. 2017;40:723-725.
    PubMed     Text format    

  25. LI YJ, Li YM
    Comment on Chen et al. Risk of Developing Type 2 Diabetes in Adolescents and Young Adults With Autism Spectrum Disorder: A Nationwide Longitudinal Study. Diabetes Care 2016;39:788-793.
    Diabetes Care. 2017;40:e59.
    PubMed     Text format    

  26. CHEN MH
    Response to Comment on Chen et al. Risk of Developing Type 2 Diabetes in Adolescents and Young Adults With Autism Spectrum Disorder: A Nationwide Longitudinal Study. Diabetes Care 2016;39:788-793.
    Diabetes Care. 2017;40:e60.
    PubMed     Text format    

  27. BRAILLON A
    Comment on O'Brien et al. Hormonal Contraception and Risk of Thromboembolism in Women With Diabetes. Diabetes Care 2017;40:233-238.
    Diabetes Care. 2017;40:e61.
    PubMed     Text format    

  28. O'BRIEN SH, Vesely SK, Schwarz EB
    Response to Comment on O'Brien et al. Hormonal Contraception and Risk of Thromboembolism in Women With Diabetes. Diabetes Care 2017;40:233-238.
    Diabetes Care. 2017;40:e62.
    PubMed     Text format    

  29. ARODA VR, Rosenstock J, Wysham C, Unger J, et al
    Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care 2016;39:1972-1
    Diabetes Care. 2017 Apr 20. pii: dc17er06d. doi: 10.2337.
    PubMed     Text format    


    Diabetes Educ

  30. MORRIS JL, Chasens ER
    Financial Difficulty: A Barrier to Self-care in Patients With Diabetes.
    Diabetes Educ. 2017 Apr 1:145721717703486. doi: 10.1177/0145721717703486.
    PubMed     Text format    

  31. BERGEN PM, Kruger DF, Taylor AD, Eid WE, et al
    Translating U-500R Randomized Clinical Trial Evidence to the Practice Setting: A Diabetes Educator/Expert Prescriber Team Approach.
    Diabetes Educ. 2017 Apr 1:145721717701579. doi: 10.1177/0145721717701579.
    PubMed     Text format     Abstract available

  32. CUBILLOS L, Estrada Del Campo Y, Harbi K, Keyserling T, et al
    Feasibility and Acceptability of a Clinic-based Mediterranean-style Diet Intervention to Reduce Cardiovascular Risk for Hispanic Americans With Type 2 Diabetes.
    Diabetes Educ. 2017 Apr 1:145721717706030. doi: 10.1177/0145721717706030.
    PubMed     Text format     Abstract available


    Diabetes Obes Metab

  33. BIESTER T, Aschemeier B, Fath M, Frey M, et al
    Effects of Dapagliflozin on Insulin-requirement, Glucose Excretion, and ss- Hydroxybutyrate levels are not related to Baseline HbA1c in Youth with Type 1 Diabetes.
    Diabetes Obes Metab. 2017 Apr 17. doi: 10.1111/dom.12975.
    PubMed     Text format     Abstract available

  34. CUSI K, Sanyal AJ, Zhang S, Hartman ML, et al
    Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes.
    Diabetes Obes Metab. 2017 Apr 17. doi: 10.1111/dom.12973.
    PubMed     Text format     Abstract available

  35. GUMMESSON A, Nyman E, Knutsson M, Karpefors M, et al
    Effect of Weight Reduction on Hemoglobin A1c in weight loss trials of Type 2 Diabetes Patients.
    Diabetes Obes Metab. 2017 Apr 18. doi: 10.1111/dom.12971.
    PubMed     Text format     Abstract available

  36. SOLINI A, Rossi C, Mazzanti CM, Proietti A, et al
    SGLT2 and SGLT1 renal expression in patients with type 2 diabetes.
    Diabetes Obes Metab. 2017 Apr 17. doi: 10.1111/dom.12970.
    PubMed     Text format     Abstract available


    Eur J Endocrinol

  37. HE Y, Qian H, Xu L, Zhang S, et al
    Association Between Estimated Glomerular Filtration Rate and Outcomes in Patients with Diabetic Foot Ulcers: a 3-year Follow-up Study.
    Eur J Endocrinol. 2017 Apr 19. pii: EJE-17-0070. doi: 10.1530/EJE-17-0070.
    PubMed     Text format     Abstract available


    Invest Ophthalmol Vis Sci

  38. SUN MH, Shariati MA, Liao YJ
    Experimental Anterior Ischemic Optic Neuropathy in Diabetic Mice Exhibited Severe Retinal Swelling Associated With VEGF Elevation.
    Invest Ophthalmol Vis Sci. 2017;58:2296-2305.
    PubMed     Text format     Abstract available


    J Diabetes Complications

  39. UNNIKRISHNAN R, Anjana RM, Amutha A, Ranjani H, et al
    Younger-onset versus older-onset type 2 diabetes: Clinical profile and complications.
    J Diabetes Complications. 2017 Mar 23. pii: S1056-8727(16)30934.
    PubMed     Text format     Abstract available

  40. HA NT, Harris M, Robinson S, Preen D, et al
    Stratification strategy for evaluating the influence of diabetes complication severity index on the risk of hospitalization: a record linkage data in Western Australia.
    J Diabetes Complications. 2017 Apr 5. pii: S1056-8727(17)30132.
    PubMed     Text format     Abstract available

  41. VIGILI DE KREUTZENBERG S, Solini A, Vitolo E, Boi A, et al
    Silent coronary heart disease in patients with type 2 diabetes: application of a screening approach in a follow-up study.
    J Diabetes Complications. 2017 Apr 4. pii: S1056-8727(17)30111.
    PubMed     Text format     Abstract available

  42. GLASHEEN WP, Renda A, Dong Y
    Diabetes Complications Severity Index (DCSI)-Update and ICD-10 translation.
    J Diabetes Complications. 2017 Mar 14. pii: S1056-8727(16)31042.
    PubMed     Text format     Abstract available

  43. EL BOUSTANY R, Taveau C, Chollet C, Velho G, et al
    Antagonism of vasopressin V2 receptor improves albuminuria at the early stage of diabetic nephropathy in a mouse model of type 2 diabetes.
    J Diabetes Complications. 2017 Apr 6. pii: S1056-8727(17)30041.
    PubMed     Text format     Abstract available

  44. WILLIAMS AN, Conway BN
    Effect of high density lipoprotein cholesterol on the relationship of serum iron and hemoglobin with kidney function in diabetes.
    J Diabetes Complications. 2017 Mar 29. pii: S1056-8727(16)31044.
    PubMed     Text format     Abstract available

  45. YEAP BB, Davis WA, Peters K, Hamilton EJ, et al
    Circulating osteocalcin is unrelated to glucose homoeostasis in adults with type 1 diabetes.
    J Diabetes Complications. 2017 Apr 4. pii: S1056-8727(17)30274.
    PubMed     Text format     Abstract available


    J Nutr

  46. JANNASCH F, Kroger J, Schulze MB
    Dietary Patterns and Type 2 Diabetes: A Systematic Literature Review and Meta-Analysis of Prospective Studies.
    J Nutr. 2017 Apr 19. pii: jn242552. doi: 10.3945/jn.116.242552.
    PubMed     Text format     Abstract available


    Metabolism

  47. MONGRAW-CHAFFIN M, LaCroix AZ, Sears DD, Garcia L, et al
    A prospective study of low fasting glucose with cardiovascular disease events and all-cause mortality: The Women's Health Initiative.
    Metabolism. 2017;70:116-124.
    PubMed     Text format     Abstract available


    N Engl J Med

  48. ROSENBERG JB, Tsui I
    Screening for Diabetic Retinopathy.
    N Engl J Med. 2017;376:1587-1588.
    PubMed     Text format    


  49. Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes.
    N Engl J Med. 2017;376:1507-1516.
    PubMed     Text format     Abstract available


    Pediatr Diabetes

  50. WEI C, Allen RJ, Tallis PM, Ryan FJ, et al
    Cognitive behavioural therapy stabilises glycaemic control in adolescents with type 1 diabetes-Outcomes from a randomised control trial.
    Pediatr Diabetes. 2017 Apr 17. doi: 10.1111/pedi.12519.
    PubMed     Text format     Abstract available

  51. COMMISSARIAT PV, Volkening LK, Guo Z, ElBach JL, et al
    Associations between major life events and adherence, glycemic control, and psychosocial characteristics in teens with type 1 diabetes.
    Pediatr Diabetes. 2017 Apr 19. doi: 10.1111/pedi.12523.
    PubMed     Text format     Abstract available

  52. VAN NAME MA, Hilliard ME, Boyle CT, Miller KM, et al
    Nighttime is the worst time: Parental fear of hypoglycemia in young children with type 1 diabetes.
    Pediatr Diabetes. 2017 Apr 21. doi: 10.1111/pedi.12525.
    PubMed     Text format     Abstract available


    PLoS One

  53. DEMAKAKOS P, Muniz-Terrera G, Nouwen A
    Type 2 diabetes, depressive symptoms and trajectories of cognitive decline in a national sample of community-dwellers: A prospective cohort study.
    PLoS One. 2017;12:e0175827.
    PubMed     Text format     Abstract available

  54. ZHU B, Wu X, Wu B, Pei D, et al
    The relationship between diabetes and colorectal cancer prognosis: A meta-analysis based on the cohort studies.
    PLoS One. 2017;12:e0176068.
    PubMed     Text format     Abstract available

  55. FONDJO LA, Owiredu WKBA, Sakyi SA, Laing EF, et al
    Vitamin D status and its association with insulin resistance among type 2 diabetics: A case -control study in Ghana.
    PLoS One. 2017;12:e0175388.
    PubMed     Text format     Abstract available

  56. MARINI MA, Fiorentino TV, Succurro E, Pedace E, et al
    Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals.
    PLoS One. 2017;12:e0175547.
    PubMed     Text format     Abstract available

  57. QIAO YC, Chen YL, Pan YH, Tian F, et al
    The change of serum tumor necrosis factor alpha in patients with type 1 diabetes mellitus: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0176157.
    PubMed     Text format     Abstract available

  58. WORKNEH MH, Bjune GA, Yimer SA
    Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: A systematic review.
    PLoS One. 2017;12:e0175925.
    PubMed     Text format     Abstract available

  59. JUN JE, Lee SE, Lee YB, Jee JH, et al
    Increase in serum albumin concentration is associated with prediabetes development and progression to overt diabetes independently of metabolic syndrome.
    PLoS One. 2017;12:e0176209.
    PubMed     Text format     Abstract available


    Retina

  60. KALDIRIM H, Yazgan S, Atalay K, Gurez C, et al
    INTRAVITREAL DEXAMETHASONE IMPLANTATION IN PATIENTS WITH DIFFERENT MORPHOLOGICAL DIABETIC MACULAR EDEMA HAVING INSUFFICIENT RESPONSE TO RANIBIZUMAB.
    Retina. 2017 Apr 19. doi: 10.1097/IAE.0000000000001648.
    PubMed     Text format     Abstract available

  61. NOURINIA R, Ahmadieh H, Nekoei E, Malekifar P, et al
    CHANGES IN CENTRAL CHOROIDAL THICKNESS AFTER TREATMENT OF DIABETIC MACULAR EDEMA WITH INTRAVITREAL BEVACIZUMAB CORRELATION WITH CENTRAL MACULAR THICKNESS AND BEST-CORRECTED VISUAL ACUITY.
    Retina. 2017 Apr 19. doi: 10.1097/IAE.0000000000001645.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: